Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of peripheral artery disease (PAD)
3.2.1.2 Technological advancements in revascularization procedures
3.2.1.3 Growing awareness and early diagnosis
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of advanced treatments
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Future market trends
3.6 Regulatory landscape
3.7 Product pipeline analysis
3.8 Reimbursement scenario
3.9 Porter’s analysis
3.10 GAP analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Treatment Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Procedures
5.2.1 Endovascular procedures
5.2.1.1 Angioplasty
5.2.1.2 Stenting
5.2.1.3 Atherectomy
5.2.2 Surgical procedures
5.2.2.1 Bypass surgery
5.2.2.2 Endarterectomy
5.3 Medications
5.3.1 Antiplatelet drugs
5.3.2 Anticoagulants
5.3.3 Cholesterol-lowering drugs
5.3.4 Pain relievers
5.3.5 Other medications
5.4 Other treatment types
Chapter 6 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Hospitals
6.3 Ambulatory surgical centers
6.4 Other end-users
Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Netherlands
7.3.7 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.2 Bayer
8.3 Boston Scientific
8.4 Cesca Therapeutics
8.5 Cook Medical
8.6 Eli Lilly and Company
8.7 Medtronic plc
8.8 Micro Medical Solutions
8.9 Pfizer
8.10 Sanofi
8.11 Terumo Corporation
8.12 Teva Pharmaceuticals
